阻斷促腎上腺皮質激素釋放激素1受體對慢性束縛應激致大鼠類抑郁癥狀的改善
[Abstract]:Objective to study the effects of restraint stress on the expression of brain-derived neurotrophic factor (brain derived neurotrophic factor,BDNF) and growth-associated protein (growth associated protein 43) in rat hypothalamus. The role of BDNF and GAP-43 in the development of depression-like symptoms induced by chronic stress and the therapeutic effect of CP-154526 were analyzed. Methods Thirty male SD rats were randomly divided into three groups: restraint stress group, CP-154526 treatment group and control group. The depression model was established in the restraint stress group by 3 hours per day for 21 days, and the adrenocorticotropic hormone releasing hormone 1 receptor (corticotrophin-releasing hormone type 1 receptor) was used to establish the depression model. CRH1R) CP-154526 treatment group has been treated with CP-154526 since the experiment, and the control group has been injected with DMSO., the solvent of CP-154526. The changes of behavior and the expression of BDNF,GAP-43 protein in hypothalamus of model rats were detected by enzyme linked immunosorbent assay (Elisa) and plasma corticotropin releasing hormone (corticotropin releasing hormonecorti,CRH) concentration; Western blot. Results compared with the control group and the treatment group, the growth of body mass in the restraint stress group decreased (P0.05), and the preference rate of sugar water decreased significantly (P0.05), and the number of piercing, standing and modification in the control group was lower than that in the control group (P0.05). But the treatment group and the control group above experiment result has no statistical difference (P0.05). The plasma CRH concentration in the restraint stress group was higher than that in the control group (P0.05), but the plasma CRH concentration in the treatment group was not significantly different from that in the control group (P0.05). The expression of BDNF,GAP-43 in hypothalamus in restraint stress group was higher than that in control group and treatment group (P0.05). Conclusion chronic restraint stress can increase the expression of BDNF,GAP-43 protein in hypothalamus and induce plasticity of hypothalamus. CP-154526 can reverse the expression of BDNF and GAP-43 protein in hypothalamus and ameliorate depressive symptoms.
【作者單位】: 第三軍醫(yī)大學大坪醫(yī)院野戰(zhàn)外科研究所老年科;第三軍醫(yī)大學大坪醫(yī)院野戰(zhàn)外科研究所神經外科;
【基金】:重慶市自然科學基金(cstc2013jj B10002)~~
【分類號】:R965
【參考文獻】
相關期刊論文 前1條
1 劉春林;阮克鋒;高君偉;吳飛;張繼全;;抑郁癥的多機制發(fā)病[J];生理科學進展;2013年04期
【共引文獻】
相關期刊論文 前8條
1 唐仕友;;經顱磁刺激聯合舍曲林治療抑郁癥療效分析[J];中國地方病防治雜志;2014年S1期
2 程博琳;方曉艷;苗明三;;抑郁癥的分子機制及中醫(yī)藥治療抑郁癥特點[J];中醫(yī)學報;2014年02期
3 潘菊華;王彥云;張永超;霍蕊莉;;丹參抗抑郁作用新探[J];環(huán)球中醫(yī)藥;2014年06期
4 劉鳳榮;;抑郁癥患者糖代謝及CRP的研究進展[J];臨床軍醫(yī)雜志;2015年03期
5 張秋霞;楊亦龍;王雅麗;路廣林;郭華;趙暉;;聶惠民教授治療抑郁癥的臨證經驗[J];世界中醫(yī)藥;2014年08期
6 付菁文;林凡凱;喬瑾淵;王斐;余躍海;;抑郁癥發(fā)生的病理生理研究進展[J];生命科學儀器;2015年01期
7 朱敏;;淺談抑郁癥的病因學研究進展[J];當代醫(yī)藥論叢;2015年09期
8 胡紅濤;;安神解郁湯與帕羅西汀治療精神分裂癥后抑郁的療效比較[J];吉林中醫(yī)藥;2015年08期
相關博士學位論文 前1條
1 宋佳;安絡小皮傘高產菌株選育、發(fā)酵工藝優(yōu)化及相關藥效研究[D];吉林大學;2015年
相關碩士學位論文 前2條
1 陳琳;加味逍遙膠囊治療62例輕中度抑郁癥氣郁化火證臨床療效觀察[D];北京中醫(yī)藥大學;2014年
2 馬迎歌;耳針(迷走神經刺激)治療抑郁的中醫(yī)證型分布與探討[D];北京中醫(yī)藥大學;2014年
【二級參考文獻】
相關期刊論文 前7條
1 趙穎琳;許崇濤;;腺苷及其受體在睡眠剝奪快速抗抑郁效應機制中的研究進展[J];國際精神病學雜志;2010年02期
2 胡小婭;李娜;費慧芝;王涵;文威;周岐新;;瑞波西汀抗抑郁作用的非轉運體抑制機制研究[J];第三軍醫(yī)大學學報;2012年19期
3 王迎新;張向榮;張志s,
本文編號:2332554
本文鏈接:http://www.sikaile.net/yixuelunwen/yiyaoxuelunwen/2332554.html